PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

API China Strengthens Its Role as Asia’s Pharma Powerhouse Heads to Chongqing for its 93rd edition

 API China, Asia’s authoritative exhibition for pharmaceutical ingredients and manufacturing, will convene its 93rd edition at the Chongqing International Expo Center from 12–14 November 2025. Held twice annually, the event is one of the largest gatherings of the pharmaceutical supply chain, bringing together more than 1,200 exhibitors and close to 30,000 industry professionals, including over 5,000 pharmaceutical manufacturers, across 70,000 square metres of exhibition space.

With a heritage spanning more than four decades, API China stands as the most established platform of its kind. Generations of industry professionals have trusted it as the meeting point to gain insight, discover innovation, and forge lasting business connections in China’s fast-evolving pharmaceutical and biopharmaceutical landscape.

Four Pillars, One Integrated Ecosystem

The exhibition’s strength lies in its breadth. Beyond active pharmaceutical ingredients, the event encompasses the full scope of pharmaceutical manufacturing. Four interlinked pillars form the backbone of the show: API China, which highlights cutting-edge APIs, biologics, and contract manufacturing expertise; PHARMEX, dedicated to the excipients that shape drug formulation; PHARMPACK, showcasing intelligent and sustainable pharmaceutical packaging; and SINOPHEX, focused on advanced machinery, cleanroom, and laboratory technologies. Together, they reflect the complete journey from molecule to medicine, offering visitors a holistic view of the ecosystem.

To ensure meaningful engagement at this scale, API China will run dedicated business matching activities designed to connect buyers and suppliers with shared priorities. By facilitating purposeful introductions, the programme turns the sheer diversity of exhibitors into tangible opportunities for collaboration and growth.

A full list of exhibitors can be accessed here: www.apichina.com.cn/#/companyList

Insights and Expertise Beyond the Exhibition Floor

Alongside the exhibition floor, API China features a robust programme of forums and conferences. Of special note is the IPEC Federation China Excipient Conference, co-organized by IPEC China and Reed Sinopharm Exhibitions. Launched in 2012, the conference is the foremost platform for excipient-focused dialogue, convening regulators, experts, and manufacturers to exchange perspectives on GMP, regulatory reforms, technological advances, and the evolving role of excipients in drug development.

Reinforcing API China’s role as a hub for industry knowledge, the 40th China Pharmaceutical Industry Market Information Conference will gather policy leaders, data experts, and enterprise representatives to examine the current landscape and outlook of China’s pharmaceutical sector. With discussions on innovation, market dynamics, and global competitiveness, the conference offers an authoritative pulse of the industry — affirming API China’s position as a catalyst for insight, collaboration, and progress.

Secure Your Spot at Asia’s Premier Pharmaceutical Marketplace

“API China is where ideas, innovations, and partnerships take root and grow,” said a spokesperson for Reed Sinopharm Exhibitions. “As the industry evolves, our commitment is to continue presenting the most trusted platform for global audiences to benefit from meaningful exchange and collaboration.”

Industry professionals are invited to pre-register for API China 2025 (Chongqing) at: https://bit.ly/93APIChinaprereg.

###

About API China

API China is the country’s leading exhibition for the pharmaceutical and biopharmaceutical industries, serving as a trusted platform for sourcing, innovation, and partnership. It brings together the full spectrum of the pharma, health, and nutrition ecosystem—from active pharmaceutical ingredients (APIs), intermediates, and excipients to formulations, packaging, manufacturing equipment, CDMO services, and biotech solutions. Organised by Reed Sinopharm Exhibitions, API China connects global professionals with China’s dynamic life sciences market through high-level exhibitions, forums, and strategic exchange.

More information: www.apichina.com.cn/en

Follow us on social media:

LinkedInhttps://www.linkedin.com/company/apichina/

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026